Jennison Associates’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-357,111
Closed -$12.5M 631
2020
Q3
$12.5M Buy
357,111
+3,994
+1% +$140K 0.01% 356
2020
Q2
$18.9M Sell
353,117
-199,612
-36% -$10.7M 0.02% 305
2020
Q1
$19.6M Buy
552,729
+4,376
+0.8% +$155K 0.02% 253
2019
Q4
$26.2M Buy
548,353
+4,749
+0.9% +$227K 0.03% 274
2019
Q3
$17.6M Sell
543,604
-54,235
-9% -$1.76M 0.02% 329
2019
Q2
$29.8M Buy
597,839
+212,949
+55% +$10.6M 0.03% 286
2019
Q1
$26M Buy
384,890
+191,359
+99% +$12.9M 0.03% 318
2018
Q4
$8.92M Sell
193,531
-1,839
-0.9% -$84.8K 0.01% 443
2018
Q3
$15.1M Buy
195,370
+1,435
+0.7% +$111K 0.01% 430
2018
Q2
$16.3M Buy
193,935
+3,183
+2% +$268K 0.02% 425
2018
Q1
$15.6M Buy
190,752
+24,497
+15% +$2M 0.02% 421
2017
Q4
$9.51M Buy
166,255
+190
+0.1% +$10.9K 0.01% 465
2017
Q3
$11.1M Sell
166,065
-390
-0.2% -$26K 0.01% 470
2017
Q2
$8.56M Sell
166,455
-3,344
-2% -$172K 0.01% 489
2017
Q1
$9.92M Hold
169,799
0.01% 484
2016
Q4
$7.09M Buy
169,799
+547
+0.3% +$22.8K 0.01% 493
2016
Q3
$8.94M Sell
169,252
-722
-0.4% -$38.1K 0.01% 477
2016
Q2
$7.12M Sell
169,974
-312,123
-65% -$13.1M 0.01% 475
2016
Q1
$19.6M Buy
482,097
+52,012
+12% +$2.11M 0.02% 405
2015
Q4
$27.9M Buy
430,085
+271,142
+171% +$17.6M 0.03% 377
2015
Q3
$11.2M Buy
158,943
+994
+0.6% +$70.2K 0.01% 495
2015
Q2
$17.6M Buy
157,949
+1,272
+0.8% +$141K 0.02% 462
2015
Q1
$14.8M Buy
156,677
+400
+0.3% +$37.7K 0.01% 464
2014
Q4
$17.5M Sell
156,277
-81,148
-34% -$9.09M 0.02% 447
2014
Q3
$14.6M Buy
237,425
+186
+0.1% +$11.4K 0.01% 458
2014
Q2
$10.9M Sell
237,239
-72,168
-23% -$3.31M 0.01% 467
2014
Q1
$12.1M Buy
309,407
+2,172
+0.7% +$85K 0.01% 473
2013
Q4
$7.36M Buy
307,235
+132,235
+76% +$3.17M 0.01% 493
2013
Q3
$4.89M Buy
+175,000
New +$4.89M 0.01% 507